Correction to Targeting Myeloid Differentiation Using Potent 2

Addition/Correction pubs.acs.org/jmc

Cite This: J. Med. Chem. XXXX, XXX, XXX−XXX

Correction to Targeting Myeloid Differentiation Using Potent 2‑Hydroxypyrazolo[1,5‑a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors Stefano Sainas, Agnese C. Pippione, Elisa Lupino, Marta Giorgis, Paola Circosta, Valentina Gaidano, Parveen Goyal, Davide Bonanni, Barbara Rolando, Alessandro Cignetti, Alex Ducime, Mikael Andersson, Michael Järvå, Rosmarie Friemann, Marco Piccinini, Cristina Ramondetti, Barbara Buccinnà, Salam Al-Karadaghi, Donatella Boschi, Giuseppe Saglio, and Marco L. Lolli* J. Med. Chem. Downloaded from pubs.acs.org by 146.185.203.253 on 01/30/19. For personal use only.

Journal of Medicinal Chemistry 2018, 61 (14), 6034−6055. DOI: 10.1021/acs.jmedchem.8b00373 Page 6052. In Acknowledgments, “PRIN 2015 (LOLM_PRIN_2015_16_01)” should be replaced with “LOLM_RIC_COMP_18_01 (Progetto PGR00978 Italia/Svezia (MAECI))”.

© XXXX American Chemical Society

A

DOI: 10.1021/acs.jmedchem.9b00057 J. Med. Chem. XXXX, XXX, XXX−XXX